Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125-Reference-Cited by-同舟云学术

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

Published:2014-11-19 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Seitz Stephan,Buchholz Stefan,Schally Andrew Victor,Weber Florian,Klinkhammer-Schalke Monika,Inwald Elisabeth C,Perez Roberto,Rick Ferenc G,Szalontay Luca,Hohla Florian,Segerer Sabine,Kwok Chui Wai,Ortmann Olaf,Engel Jörg Bernhard

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-847.pdf

Reference30 articles.

1. Fost C, Duwe F, Hellriegel M, Schweyer S, Emons G, Grundker C: Targeted chemotherapy for triple-negative breast cancers via LHRH receptor. Oncol Rep. 2011, 25: 1481-1487.

2. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM: The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 2007, 13: 2329-2334. 10.1158/1078-0432.CCR-06-1109.

3. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007, 13: 4429-4434. 10.1158/1078-0432.CCR-06-3045.

4. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007, 109: 1721-1728. 10.1002/cncr.22618.

5. Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K, Mitchell EP: Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s surveillance, epidemiology, and end results database. Cancer. 2007, 110: 876-884. 10.1002/cncr.22836.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The chemistry of disorazoles and structure-activity relationships: An update;Tetrahedron;2024-04

2. The Disorazole Z Family of Highly Potent Anticancer Natural Products from Sorangium cellulosum: Structure, Bioactivity, Biosynthesis, and Heterologous Expression;Microbiology Spectrum;2023-08-17

3. Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers;Frontiers in Endocrinology;2023-03-28

4. Synthese und Biologische Untersuchungen von C(13)/C(13′)‐Bis(desmethyl)disorazol Z**;Angewandte Chemie;2022-12-20

5. Synthesis and Biological Evaluation of C(13)/C(13′)‐Bis(desmethyl)disorazole Z**;Angewandte Chemie International Edition;2022-12-20